XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -23.61%4.61B | ---- | -44.03%6.04B | ---- | -23.44%10.79B | ---- | 10.73%14.09B | ---- | 13.79%12.73B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -26.56%-381.33M | ---- | -6.62%-301.29M | ---- | -85.21%-282.6M | ---- | -0.49%-152.58M | ---- | 13.85%-151.84M |
Interest expense - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8.07%1.39B |
Investment loss (gain) | ---- | ---- | ---- | ---254.02M | ---- | ---- | ---- | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | -185.27%-695.64M | ---- | 83.01%-243.86M | ---- | 10.74%-1.44B | ---- | -64.76%-1.61B | ---- | 40.91%-975.98M |
Impairment and provisions: | ---- | 2,236.88%685.6M | ---- | -106.45%-32.08M | ---- | 81.25%497.08M | ---- | 69.63%274.25M | ---- | 4.04%161.67M |
-Impairment of trade receivables (reversal) | ---- | 2,236.88%685.6M | ---- | ---32.08M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -8.70%62.87M |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | 81.25%497.08M | ---- | 177.57%274.25M | ---- | 14.18%98.8M |
Revaluation surplus: | ---- | 228.29%171.59M | ---- | -157.57%-133.75M | ---- | 171.52%232.31M | ---- | -1,918.37%-324.83M | ---- | 29.30%17.86M |
-Fair value of investment properties (increase) | ---- | 170.71%94.64M | ---- | 61.72%-133.85M | ---- | -792.00%-349.68M | ---- | -329.43%-39.2M | ---- | 1,433.88%17.09M |
-Other fair value changes | ---- | 75,342.16%76.95M | ---- | -99.98%102K | ---- | 303.76%581.99M | ---- | -36,860.88%-285.63M | ---- | -94.85%777K |
Asset sale loss (gain): | ---- | -2,526.06%-194.38M | ---- | 103.11%8.01M | ---- | -485.23%-257.79M | ---- | 1,598.43%66.92M | ---- | 100.66%3.94M |
-Loss (gain) from sale of subsidiary company | ---- | -3,331.82%-173.55M | ---- | 101.98%5.37M | ---- | -666.42%-271.21M | ---- | 661.65%47.88M | ---- | 98.77%-8.53M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -256.82%-20.83M | ---- | -1.03%13.28M | ---- | -16.72%13.42M | ---- | 29.27%16.11M | ---- | -87.08%12.47M |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---10.64M | ---- | ---- | ---- | --2.92M | ---- | ---- |
Depreciation and amortization: | ---- | 3.50%2.91B | ---- | 8.47%2.81B | ---- | 21.20%2.59B | ---- | 21.24%2.14B | ---- | 33.07%1.76B |
-Amortization of intangible assets | ---- | -4.23%181.41M | ---- | 7.11%189.41M | ---- | 6.34%176.84M | ---- | 24.09%166.29M | ---- | 9.26%134.01M |
Financial expense | ---- | 14.36%2.12B | ---- | 27.38%1.86B | ---- | 2.66%1.46B | ---- | --1.42B | ---- | ---- |
Exchange Loss (gain) | ---- | -276.14%-78.44M | ---- | 67.27%-20.86M | ---- | 21.15%-63.73M | ---- | -248.41%-80.82M | ---- | -63.78%54.46M |
Special items | ---- | 231.22%156.8M | ---- | --47.34M | ---- | ---- | ---- | 99.87%-122K | ---- | -198.15%-97.53M |
Operating profit before the change of operating capital | ---- | -4.77%9.31B | ---- | -27.73%9.78B | ---- | -14.51%13.53B | ---- | 6.27%15.82B | ---- | 26.31%14.89B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 233.51%751.31M | ---- | -208.10%-562.75M | ---- | 89.20%-182.65M | ---- | -1,807.49%-1.69B | ---- | 142.41%99.01M |
Accounts receivable (increase)decrease | ---- | 313.58%2.09B | ---- | 69.26%-979.53M | ---- | -107.43%-3.19B | ---- | -170.65%-1.54B | ---- | 129.09%2.17B |
Accounts payable increase (decrease) | ---- | -514.23%-1.11B | ---- | -136.59%-181.04M | ---- | -16.36%494.78M | ---- | 116.55%591.57M | ---- | -131.54%-3.58B |
Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | 158.56%1.2B | ---- | 58.50%-2.04B | ---- | -42.97%-4.92B |
Cash from business operations | ---- | 9.04%12.69B | ---- | -1.74%11.64B | ---- | 6.28%11.85B | ---- | 28.57%11.15B | ---- | -27.62%8.67B |
China income tax paid | ---- | 16.18%-1.35B | ---- | 18.11%-1.61B | ---- | 31.28%-1.97B | ---- | -31.33%-2.87B | ---- | -17.36%-2.18B |
Special items of business | -51.31%3.68B | ---- | 59.74%7.57B | ---- | 14.30%4.74B | ---- | -39.85%4.14B | ---- | 70.79%6.89B | ---- |
Net cash from operations | -51.31%3.68B | 13.09%11.34B | 59.74%7.57B | 1.53%10.03B | 14.30%4.74B | 19.30%9.88B | -39.85%4.14B | 27.64%8.28B | 70.79%6.89B | -35.89%6.49B |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 26.56%381.33M | ---- | 6.62%301.29M | ---- | 85.21%282.6M | ---- | 0.49%152.58M | ---- | -13.85%151.84M |
Dividend received - investment | ---- | -7.06%380.32M | ---- | 42.21%409.2M | ---- | -6.19%287.74M | ---- | 78.32%306.73M | ---- | 48.34%172.01M |
Loan receivable (increase) decrease | ---- | -18.64%-1.81B | ---- | -122.16%-1.52B | ---- | -15,246.89%-685.7M | ---- | 98.54%-4.47M | ---- | -214.65%-305.58M |
Decrease in deposits (increase) | ---- | -16.93%-16.31M | ---- | -112.81%-13.95M | ---- | -64.49%108.88M | ---- | 199.60%306.58M | ---- | -1,170.49%-307.82M |
Sale of fixed assets | ---- | 63.68%240.01M | ---- | 4.90%146.64M | ---- | 167.10%139.79M | ---- | -25.04%52.34M | ---- | 23.85%69.82M |
Purchase of fixed assets | ---- | -2.09%-6B | ---- | 33.28%-5.88B | ---- | -8.42%-8.81B | ---- | -16.17%-8.13B | ---- | 18.68%-7B |
Selling intangible assets | ---- | --36.48M | ---- | ---- | ---- | 33.63%14.97M | ---- | 3,109.17%11.2M | ---- | --349K |
Purchase of intangible assets | ---- | 25.75%-60.63M | ---- | 58.84%-81.66M | ---- | 11.33%-198.42M | ---- | -70.25%-223.77M | ---- | -68.68%-131.43M |
Sale of subsidiaries | ---- | 3,109.85%726.33M | ---- | -90.17%22.63M | ---- | 812.96%230.11M | ---- | 181.71%25.21M | ---- | -107.23%-30.85M |
Acquisition of subsidiaries | ---- | 568.88%6.63M | ---- | 99.32%-1.41M | ---- | 67.87%-207.96M | ---- | -11.10%-647.17M | ---- | -88.69%-582.52M |
Recovery of cash from investments | ---- | -95.86%6.55M | ---- | 555.56%158.16M | ---- | -59.86%24.13M | ---- | --60.11M | ---- | ---- |
Cash on investment | ---- | 12.51%-915.35M | ---- | 65.61%-1.05B | ---- | -1,179.40%-3.04B | ---- | 82.65%-237.79M | ---- | 48.00%-1.37B |
Other items in the investment business | 43.61%-1.46B | ---28.18M | 33.48%-2.59B | ---- | 46.20%-3.9B | ---348.32M | -133.81%-7.24B | ---- | 44.74%-3.1B | 14.27%-124.86M |
Net cash from investment operations | 43.61%-1.46B | 6.07%-7.05B | 33.48%-2.59B | 38.49%-7.51B | 46.20%-3.9B | -46.62%-12.21B | -133.81%-7.24B | 11.95%-8.32B | 44.74%-3.1B | 14.30%-9.45B |
Net cash before financing | -55.33%2.22B | 70.19%4.29B | 491.59%4.97B | 208.21%2.52B | 127.16%840.83M | -4,971.33%-2.33B | -181.64%-3.1B | 98.45%-45.92M | 341.54%3.79B | -224.38%-2.97B |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | -13.75%31.95B | ---- | -7.69%37.05B | ---- | 13.07%40.13B | ---- | 28.11%35.49B | ---- | -1.93%27.71B |
Refund | ---- | -4.44%-31.56B | ---- | 13.33%-30.22B | ---- | -17.52%-34.87B | ---- | -22.50%-29.67B | ---- | -14.64%-24.22B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --11.6B | ---- | ---- | ---- | ---- |
Interest paid - financing | ---- | -11.08%-2.75B | ---- | -17.36%-2.48B | ---- | -10.85%-2.11B | ---- | -3.42%-1.9B | ---- | -26.61%-1.84B |
Dividends paid - financing | ---- | 9.77%-3.29B | ---- | 6.78%-3.65B | ---- | -34.93%-3.91B | ---- | -10.49%-2.9B | ---- | -20.82%-2.62B |
Absorb investment income | ---- | -54.79%73.55M | ---- | -53.39%162.7M | ---- | 28.78%349.03M | ---- | 182.34%271.04M | ---- | 10.72%96M |
Issuance expenses and redemption of securities expenses | ---- | ---43.91M | ---- | ---- | ---- | -2,042.29%-2.85B | ---- | ---132.9M | ---- | ---- |
Other items of the financing business | 51.79%-1.71B | 98.21%-37.06M | -188.55%-3.54B | 53.31%-2.07B | -35.26%4B | -4,043.84%-4.43B | 318.65%6.18B | 93.69%-106.9M | -44.30%-2.83B | -321.48%-1.69B |
Net cash from financing operations | 51.79%-1.71B | -314.78%-5.86B | -188.55%-3.54B | -138.27%-1.41B | -35.26%4B | 326.84%3.69B | 318.65%6.18B | 132.52%865.58M | -44.30%-2.83B | -142.01%-2.66B |
Effect of rate | 165.14%579.51M | -13.50%-769.18M | 14.68%-889.61M | -293.17%-677.71M | -1,328.06%-1.04B | -1.13%350.83M | -75.57%84.91M | 172.48%354.85M | 150.68%347.51M | -14.73%-489.58M |
Net Cash | -64.07%514.9M | -242.42%-1.58B | -70.39%1.43B | -19.02%1.11B | 57.08%4.84B | 66.65%1.37B | 218.60%3.08B | 114.56%819.66M | 127.41%967.14M | -203.89%-5.63B |
Begining period cash | -22.46%8.09B | 4.28%10.44B | 4.28%10.44B | 20.70%10.01B | 20.70%10.01B | 16.50%8.29B | 16.50%8.29B | -46.23%7.12B | -46.23%7.12B | 60.54%13.24B |
Cash at the end | -16.33%9.19B | -22.46%8.09B | -20.46%10.98B | 4.28%10.44B | 20.49%13.81B | 20.70%10.01B | 35.88%11.46B | 16.50%8.29B | -6.55%8.43B | -46.23%7.12B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.